Search research articles
Contact Us
Filters
Showing results (251-260 of 269) with videos related to
Page
of 27
Sort By:
Traffic (Copenhagen, Denmark)
|
November 10, 2022
Multiplexed cellular profiling identifies an organoselenium compound as an inhibitor of CRM1-mediated nuclear export
Lucia Jimenez, Victor Mayoral-Varo, Carlos Amenábar, et al.
Journal of Medicinal Chemistry
|
May 29, 2020
Azidothymidine "Clicked" into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors
Emanuela Berrino, Andrea Angeli, Dmitry D Zhdanov, et al.
Chemmedchem
|
September 25, 2024
Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Jaydeo T Kilbile, Suryakant B Sapkal, Gioele Renzi, et al.
Molecular Cancer Therapeutics
|
August 19, 2016
Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models
Derek P Logsdon, Michelle Grimard, Meihua Luo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 24, 2020
The role of carbonic anhydrases in extinction of contextual fear memory
Scheila Daiane Schmidt, Alessia Costa, Barbara Rani, et al.
Journal of Chemical Information and Modeling
|
May 12, 2025
Discovery of <i>Trypanosoma cruzi</i> Carbonic Anhydrase Inhibitors by a Combination of Ligand- and Structure-Based Virtual Screening
Denis N Prada Gori, Emilia M Barrionuevo, Lucas N Alberca, et al.
Journal of Medicinal Chemistry
|
June 1, 2018
Discovery of β-Adrenergic Receptors Blocker-Carbonic Anhydrase Inhibitor Hybrids for Multitargeted Antiglaucoma Therapy
Alessio Nocentini, Mariangela Ceruso, Silvia Bua, et al.
Journal of Medicinal Chemistry
|
October 28, 2025
Discovery of First-in-Class Carbonic Anhydrase/Histone Deacetylase Dual Inhibitors with Antiproliferative Activity in Cancer Cells
Murat Bozdag, Nabil Mroweh, Alessia Raucci, et al.
Metabolites
|
October 17, 2020
Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment
Andrea Angeli, Fabrizio Carta, Alessio Nocentini, et al.
Frontiers in Chemistry
|
February 5, 2024
Origanum majorana L. polyphenols: <i>in vivo</i> antiepileptic effect, in silico evaluation of their bioavailability, and interaction with the NMDA receptor
Amal Amaghnouje, Mohamed Chebaibi, Saeed M Aldossari, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 269) with videos related to
Sort By:
Page
of 27
Traffic (Copenhagen, Denmark)
|
November 10, 2022
Multiplexed cellular profiling identifies an organoselenium compound as an inhibitor of CRM1-mediated nuclear export
Lucia Jimenez, Victor Mayoral-Varo, Carlos Amenábar, et al.
Journal of Medicinal Chemistry
|
May 29, 2020
Azidothymidine "Clicked" into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors
Emanuela Berrino, Andrea Angeli, Dmitry D Zhdanov, et al.
Chemmedchem
|
September 25, 2024
Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Jaydeo T Kilbile, Suryakant B Sapkal, Gioele Renzi, et al.
Molecular Cancer Therapeutics
|
August 19, 2016
Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models
Derek P Logsdon, Michelle Grimard, Meihua Luo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 24, 2020
The role of carbonic anhydrases in extinction of contextual fear memory
Scheila Daiane Schmidt, Alessia Costa, Barbara Rani, et al.
Journal of Chemical Information and Modeling
|
May 12, 2025
Discovery of <i>Trypanosoma cruzi</i> Carbonic Anhydrase Inhibitors by a Combination of Ligand- and Structure-Based Virtual Screening
Denis N Prada Gori, Emilia M Barrionuevo, Lucas N Alberca, et al.
Journal of Medicinal Chemistry
|
June 1, 2018
Discovery of β-Adrenergic Receptors Blocker-Carbonic Anhydrase Inhibitor Hybrids for Multitargeted Antiglaucoma Therapy
Alessio Nocentini, Mariangela Ceruso, Silvia Bua, et al.
Journal of Medicinal Chemistry
|
October 28, 2025
Discovery of First-in-Class Carbonic Anhydrase/Histone Deacetylase Dual Inhibitors with Antiproliferative Activity in Cancer Cells
Murat Bozdag, Nabil Mroweh, Alessia Raucci, et al.
Metabolites
|
October 17, 2020
Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment
Andrea Angeli, Fabrizio Carta, Alessio Nocentini, et al.
Frontiers in Chemistry
|
February 5, 2024
Origanum majorana L. polyphenols: <i>in vivo</i> antiepileptic effect, in silico evaluation of their bioavailability, and interaction with the NMDA receptor
Amal Amaghnouje, Mohamed Chebaibi, Saeed M Aldossari, et al.
Page
of 27